Articles published by AbCellera Biologics Inc.

< Previous 1 2 3 4 Next >

AbCellera to Collaborate with Biogen to Discover Therapeutic Antibodies for Neurological Conditions

March 11, 2024

From AbCellera Biologics Inc.

Via Business Wire

Tickers ABCL

AbCellera Announces Four Presentations on T-Cell Engagers at AACR 2024

March 05, 2024

From AbCellera Biologics Inc.

Via Business Wire

Tickers ABCL

AbCellera Announces Resignation of Board Member

February 23, 2024

From AbCellera Biologics Inc.

Via Business Wire

Tickers ABCL

AbCellera to Present at Upcoming Investor Conferences in March

February 22, 2024

From AbCellera Biologics Inc.

Via Business Wire

Tickers ABCL

AbCellera Reports Full Year 2023 Business Results

February 20, 2024

From AbCellera Biologics Inc.

Via Business Wire

Tickers ABCL

AbCellera to Report Full Year 2023 Financial Results on February 20, 2024

January 23, 2024

From AbCellera Biologics Inc.

Via Business Wire

Tickers ABCL

AbCellera to Present at the 42nd Annual J.P. Morgan Healthcare Conference on January 10, 2024

December 20, 2023

From AbCellera Biologics Inc.

Via Business Wire

Tickers ABCL

AbCellera to Present at the Piper Sandler 35th Annual Healthcare Conference on November 30, 2023

November 16, 2023

From AbCellera Biologics Inc.

Via Business Wire

Tickers ABCL

AbCellera Presents New Data on Two T-Cell Engager Programs at SITC 2023

November 03, 2023

From AbCellera Biologics Inc.

Via Business Wire

Tickers ABCL

AbCellera Reports Q3 2023 Business Results

November 02, 2023

From AbCellera Biologics Inc.

Via Business Wire

Tickers ABCL

Prelude Therapeutics and AbCellera Enter Partnership to Develop First-in-Class Precision Antibody Drug Conjugates in Oncology

November 01, 2023

From AbCellera Biologics Inc.

Via Business Wire

Tickers ABCL PRLD

AbCellera to Present at the Jefferies London Healthcare Conference on November 14, 2023

October 31, 2023

From AbCellera Biologics Inc.

Via Business Wire

Tickers ABCL

AbCellera to Report Third Quarter 2023 Financial Results on November 2, 2023

October 11, 2023

From AbCellera Biologics Inc.

Via Business Wire

Tickers ABCL

AbCellera Announces Two T-Cell Engager Presentations at SITC 2023

September 27, 2023

From AbCellera Biologics Inc.

Via Business Wire

Tickers ABCL

AbCellera Expands Multi-Target Antibody Discovery Collaboration with Regeneron

September 20, 2023

From AbCellera Biologics Inc.

Via Business Wire

Tickers ABCL

AbCellera Announces Collaboration with Incyte to Accelerate the Discovery and Development of Therapeutic Antibodies in Oncology

September 13, 2023

From AbCellera Biologics Inc.

Via Business Wire

Tickers ABCL

AbCellera Reports Q2 2023 Business Results

August 03, 2023

From AbCellera Biologics Inc.

Via Business Wire

Tickers ABCL

AbCellera Announces that the U.S. Patent Trial and Appeal Board Has Denied Berkeley Lights’ Request for Rehearing

July 24, 2023

From AbCellera Biologics Inc.

Via Business Wire

Tickers ABCL

AbCellera to Report Second Quarter 2023 Financial Results on August 3, 2023

July 06, 2023

From AbCellera Biologics Inc.

Via Business Wire

Tickers ABCL

AbCellera to Present at the Goldman Sachs 44th Annual Global Healthcare Conference on June 13, 2023

May 29, 2023

From AbCellera Biologics Inc.

Via Business Wire

Tickers ABCL

AbCellera Partners with the Governments of Canada and British Columbia to Advance Drug Development Capabilities and Infrastructure that Will Accelerate Innovative Medicines to Patients

May 24, 2023

From AbCellera Biologics Inc.

Via Business Wire

Tickers ABCL

AbCellera Reports Q1 2023 Business Results

May 04, 2023

From AbCellera Biologics Inc.

Via Business Wire

Tickers ABCL

AbCellera Presents New Data on T-Cell Engager Platform at AACR 2023

April 17, 2023

From AbCellera Biologics Inc.

Via Business Wire

Tickers ABCL

AbCellera to Present at the 2023 Bloom Burton & Co. Healthcare Investor Conference on April 25, 2023

April 11, 2023

From AbCellera Biologics Inc.

Via Business Wire

Tickers ABCL

AbCellera to Report First Quarter 2023 Financial Results on May 4, 2023

April 06, 2023

From AbCellera Biologics Inc.

Via Business Wire

Tickers ABCL

AbCellera and RQ Bio Partner to Accelerate the Advancement of New Therapies for Infectious Disease

March 22, 2023

From AbCellera Biologics Inc.

Via Business Wire

Tickers ABCL

AbCellera Announces Two Presentations on T-Cell Engager Discovery at AACR 2023

March 14, 2023

From AbCellera Biologics Inc.

Via Business Wire

Tickers ABCL

AbCellera to Present at the Cowen 43rd Annual Health Care Conference on March 6, 2023

February 23, 2023

From AbCellera Biologics Inc.

Via Business Wire

Tickers ABCL

AbCellera Reports Full Year 2022 Business Results

February 21, 2023

From AbCellera Biologics Inc.

Via Business Wire

Tickers ABCL

AbCellera to Present at the SVB Securities Global Biopharma Conference on February 15, 2023

February 01, 2023

From AbCellera Biologics Inc.

Via Business Wire

Tickers ABCL

< Previous 1 2 3 4 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io. Quotes delayed at least 20 minutes. Market data may be delayed. Research information, not personalized advice.